* Actelion Q3 results
* Tuesday Oct 20, 0500 GMT
* Q3 net profit seen falling 3 percent to 109 million Sfr ($107 million)
ZURICH, Oct 14 (Reuters) - Following is a breakdown of analysts' forecasts for Actelion. Europe's largest biotech company is due to report figures on Oct 20.
(Figures in million Swiss francs; EPS in francs)
Q3
Mean Median High Low No. Yr ago Change% Prev.Q Total revenue 451 454 465 428 11 394 14.5 450 Revenue - Tracleer 391 392 399 376 11 341 14.7 387 Operating profit 126 129 139 112 11 138 -8.7 121 Pretax profit 121 123 132 108 11 121 0.0 129 Net income 109 112 120 97 11 112 -2.7 116 EPS 0.90 0.90 1.01 0.79 11 0.95 -5.3 0.98
9 Months
Mean Median High Low No. Yr ago Change% Total revenue 1,307 1,309 1,320 1,283 11 1,070 22.1 Revenue - Tracleer 1,130 1,131 1,138 1,115 11 946 19.5 Operating profit 369 372 382 354 11 275 34.2 Pretax profit 363 365 374 349 11 260 39.6 Net income 328 330 338 316 11 239 37.2 EPS 2.75 2.75 2.86 2.64 11 2.02 36.1
FY2009
Mean Median High Low No. Yr ago Change% Total revenue 1,754 1,773 1,807 1,658 11 1,474 19.0 Revenue - Tracleer 1,517 1,520 1,542 1,481 11 1,294 17.2 Operating profit 442 448 466 404 11 371 19.1 Pretax profit 432 436 456 392 11 353 22.4 Net income 390 393 411 354 11 322 21.1 EPS 3.24 3.24 3.49 2.87 11 2.60 24.6
FY2010
Mean Median High Low No. Total revenue 1,902 1,919 2,004 1,711 11 Revenue - Tracleer 1,648 1,661 1,755 1,466 11 Operating profit 508 489 628 440 11 Pretax profit 501 479 625 429 11 Net income 447 431 550 373 11 EPS 3.71 3.64 4.64 3.00 11 Data provided by Inquiry Financial Europe AB (www.consensusestimates.com) Estimates were obtained from the following banks: Bank of America - Merrill Lynch, Citi, Exane BNP Paribas, Helvea, JP Morgan, Kepler Capital Markets, Morgan Stanley, Nomura Securities, Piper Jaffrey, Raymond James, ZKB ($1=1.019 Swiss Franc) (Editing by Jon Loades-Carter)